Document Detail


National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
MedLine Citation:
PMID:  12380577     Owner:  KIE     Status:  MEDLINE    
Abstract/OtherAbstract:
Objective: Our objective was to study the attitudes of Canadian physicians toward product presentations by pharmaceutical representatives (PRs), the use of inducements by the pharmaceutical industry, and methods to improve the quality of prescribing information provided to physicians. Design: We used a mailed survey. Participants: A random sample of 550 Canadian physicians in all settings was chosen. Outcome measures: The main outcome measure was the proportion of respondents agreeing with a series of statements. Results: The response rate was 262 of 525 deliverable surveys (50 per cent). Respondents had a mean of 4.2 interactions per week with PRs. Of the 262 respondents (5.8 per cent of data were incomplete), 193 (80 per cent) believed that PRs overemphasize their products' effectiveness, 108 (45 per cent) thought PRs do not present fairly the drugs' negative aspects, and 223 (92 per cent) felt that PRs have production promotion as a goal. Most, 175 (70 per cent), believe that drug-detailing affects physicians' prescribing behavior. Most, 210 (86 per cent), considered drug samples acceptable, but fewer agreed that other inducements were acceptable. Of the respondents, 183 (74 per cent) agreed that PRs should be required to use guidelines for standardized, comprehensive drug-detailing, and 165 (65 per cent) agreed that face-to-face drug-detailing by PRs using standardized guidelines would be an effective way to receive information. Conclusions: There is dissatisfaction among Canadian physicians about the quality of information provided by the pharmaceutical industry. Standardized, comprehensive guidelines would be accepted by physicians as one improvement.
Authors:
D Strang; M Gagnon; W Molloy; M Bedard; P Darzins; E Etchells; W Davidson
Related Documents :
24981387 - Tapping, pulling, probing: atomic force microscopy in drug discovery.
10322277 - Innovation and the workplace.
21073667 - Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevan...
1485197 - The gap between legal rules and practice in advertising non-registered pharmaceutical p...
22522587 - Fitness levels and physical activity among class a drug users entering prison.
24120657 - Can nanomedicines kill cancer stem cells?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals (Royal College of Physicians and Surgeons of Canada)     Volume:  29     ISSN:  0035-8800     ISO Abbreviation:  Ann R Coll Physicians Surg Can     Publication Date:  1996 Dec 
Date Detail:
Created Date:  2002-10-15     Completed Date:  2002-11-20     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7505204     Medline TA:  Ann R Coll Physicians Surg Can     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  474-8     Citation Subset:  E    
Affiliation:
Dept. of Internal Medicine, University of Manitoba, 409 Tache Ave., Winnipeg MB R2H 2A6, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Advertising as Topic
Attitude of Health Personnel*
Canada
Data Collection
Drug Industry*
Drug Prescriptions
Financial Support
Gift Giving
Guidelines as Topic
Humans
Information Dissemination
Interprofessional Relations*
Pharmaceutical Preparations
Physician's Practice Patterns
Physicians* / psychology
Chemical
Reg. No./Substance:
0/Pharmaceutical Preparations

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ottomane's pharmacies in Istanbul
Next Document:  Refusal of treatment, leading to death: towards optimization of informed consent.